Published in J Exp Med on January 01, 1992
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression. Proc Natl Acad Sci U S A (1998) 4.53
Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med (1996) 3.36
Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med (1993) 3.04
CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med (1998) 2.69
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med (1994) 2.61
Successful T cell priming in B cell-deficient mice. J Exp Med (1995) 2.52
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
A fail-safe mechanism for maintaining self-tolerance. J Exp Med (1992) 2.10
Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest (1993) 2.00
Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc Natl Acad Sci U S A (1996) 1.85
B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes. J Exp Med (1993) 1.84
Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med (1998) 1.83
A role for B cells in the development of T cell helper function in a malaria infection in mice. Proc Natl Acad Sci U S A (1998) 1.73
Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins. Blood (2005) 1.71
Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J Exp Med (1992) 1.65
Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest (1992) 1.64
"Anergy" of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype. J Exp Med (1994) 1.60
Activating systemic autoimmunity: B's, T's, and tolls. Curr Opin Immunol (2009) 1.60
A two-step, two-signal model for the primary activation of precursor helper T cells. Proc Natl Acad Sci U S A (1999) 1.58
Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J Exp Med (1996) 1.58
In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J Exp Med (1993) 1.57
Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells. J Exp Med (1996) 1.50
Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Natl Acad Sci U S A (1995) 1.49
The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J Virol (1997) 1.48
Suppressive effect of antibody on processing of T cell epitopes. J Exp Med (1993) 1.48
B cells "transduced" with TAT-fusion proteins can induce tolerance and protect mice from diabetes and EAE. Clin Immunol (2011) 1.44
The anatomy of T-cell activation and tolerance. Proc Natl Acad Sci U S A (1996) 1.42
Human CD14hi monocytes and myeloid dendritic cells provide a cell contact-dependent costimulatory signal for early CD40 ligand expression. Blood (2010) 1.39
Regulatory B cells in autoimmune diseases. Cell Mol Immunol (2013) 1.36
CD4+ T cell activation and tolerance induction in B cell knockout mice. J Exp Med (1996) 1.32
Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo. J Exp Med (1994) 1.31
Tolerogenicity of resting and activated B cells. J Exp Med (1994) 1.25
Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets. Immunol Res (2009) 1.24
Epitope-specific tolerance induction with an engineered immunoglobulin. Proc Natl Acad Sci U S A (1996) 1.24
Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation. Proc Natl Acad Sci U S A (2006) 1.23
Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID). Immunology (1998) 1.23
Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J Clin Invest (2000) 1.22
In vivo induction of tolerance in murine CD4+ cell subsets. J Exp Med (1993) 1.22
Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo. J Exp Med (1998) 1.21
Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant. J Exp Med (1998) 1.20
B cells directly tolerize CD8(+) T cells. J Exp Med (1998) 1.20
B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells. Mol Ther (2010) 1.17
Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell help. J Exp Med (2006) 1.17
B cells are not essential for peripheral T-cell tolerance. Proc Natl Acad Sci U S A (1996) 1.15
Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: the IgG scaffold is important for induction and maintenance of immune hyporesponsiveness. Proc Natl Acad Sci U S A (1999) 1.15
B cells and immunological tolerance. J Invest Dermatol (2009) 1.15
Transferable anergy: superantigen treatment induces CD4+ T cell tolerance that is reversible and requires CD4-CD8- cells and interferon gamma. J Exp Med (1997) 1.15
Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes. J Clin Invest (2003) 1.14
Thymus epithelium induces tissue-specific tolerance. J Exp Med (1993) 1.13
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein. Eur J Immunol (2010) 1.13
B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr) mice. J Immunol (2011) 1.12
Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes. Proc Natl Acad Sci U S A (1993) 1.12
Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells. Am J Transplant (2012) 1.10
B cell antigen presentation in the initiation of follicular helper T cell and germinal center differentiation. J Immunol (2014) 1.07
Induction of alloantigen-specific tolerance by B cells from CD40-deficient mice. Proc Natl Acad Sci U S A (1996) 1.07
B cells and antibodies are required for resistance to the parasitic gastrointestinal nematode Trichuris muris. Infect Immun (2001) 1.05
Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide. J Exp Med (1997) 1.05
Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials. Br J Haematol (2008) 1.04
Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes. Mol Med (1997) 1.04
Immunoglobulin heavy chain constant regions regulate immunity and tolerance to idiotypes of antibody variable regions. Proc Natl Acad Sci U S A (2002) 1.02
Visualizing the T-cell response elicited by oral administration of soluble protein antigen. Immunology (1999) 1.00
Stimulation with specific antigen can block superantigen-mediated deletion of T cells in vivo. Proc Natl Acad Sci U S A (1994) 1.00
Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs. J Exp Med (1993) 1.00
Immune tolerance induction to factor IX through B cell gene transfer: TLR9 signaling delineates between tolerogenic and immunogenic B cells. Mol Ther (2014) 0.98
Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis. J Exp Med (1998) 0.98
B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathway. J Immunol (2008) 0.97
Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice. J Exp Med (1993) 0.93
Golgi phosphoprotein 2 in physiology and in diseases. Cell Biosci (2012) 0.92
Efficient peripheral clonal elimination of B lymphocytes in MRL/lpr mice bearing autoantibody transgenes. J Exp Med (1998) 0.92
Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cells. J Immunol (2008) 0.92
Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1. Blood (2008) 0.91
B-Cell Gene Therapy for Tolerance Induction: Host but Not Donor B-Cell Derived IL-10 is Necessary for Tolerance. Front Microbiol (2011) 0.90
Alloantigen presentation by B cells: analysis of the requirement for B-cell activation. Immunology (1995) 0.90
In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen. J Virol (1996) 0.90
Costimulation via lymphocyte function-associated antigen 1 in the absence of CD28 ligation promotes anergy of naive CD4+ T cells. Proc Natl Acad Sci U S A (2001) 0.89
Human invariant NKT cell subsets differentially promote differentiation, antibody production, and T cell stimulation by B cells in vitro. J Immunol (2013) 0.89
Toll-like receptor 4-activated B cells out-compete Toll-like receptor 9-activated B cells to establish peripheral immunological tolerance. Proc Natl Acad Sci U S A (2012) 0.89
Immune regulation of transgene expression in the brain: B cells regulate an early phase of elimination of transgene expression from adenoviral vectors. Viral Immunol (2006) 0.88
Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro. J Virol (1995) 0.88
Failure of SCID mice to generate an oral tolerogen after a feed of ovalbumin: a role for a functioning gut-associated lymphoid system. Immunology (1994) 0.87
IgE-mediated enhancement of CD4+ T cell responses in mice requires antigen presentation by CD11c+ cells and not by B cells. PLoS One (2011) 0.87
Resident bacteria-stimulated IL-10-secreting B cells ameliorate T cell-mediated colitis by inducing Tr-1 cells that require IL-27-signaling. Cell Mol Gastroenterol Hepatol (2015) 0.86
Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease. Immunology (1994) 0.86
Plasmacytoid precursor dendritic cells from NOD mice exhibit impaired function: are they a component of diabetes pathogenesis? Diabetes (2008) 0.85
Potential impact of B cells on T cell function in multiple sclerosis. Mult Scler Int (2011) 0.85
Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells. J Immunol (2011) 0.85
Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells. J Immunol (2007) 0.85
Reprogrammed quiescent B cells provide an effective cellular therapy against chronic experimental autoimmune encephalomyelitis. Eur J Immunol (2011) 0.85
Microfluidic squeezing for intracellular antigen loading in polyclonal B-cells as cellular vaccines. Sci Rep (2015) 0.84
CD40-activated B cells can efficiently prime antigen-specific naïve CD8+ T cells to generate effector but not memory T cells. PLoS One (2012) 0.84
Potential importance of B cells in aging and aging-associated neurodegenerative diseases. Semin Immunopathol (2017) 0.83
Anergy in memory CD4+ T cells is induced by B cells. J Immunol (2008) 0.83
Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen. J Virol (1999) 0.83
A blood-borne antigen induces rapid T-B cell contact: a potential mechanism for tolerance induction. Immunology (2002) 0.83
The SCHOOL of nature: I. Transmembrane signaling. Self Nonself (2010) 0.82
Human Vδ2(+) γδ T Cells Differentially Induce Maturation, Cytokine Production, and Alloreactive T Cell Stimulation by Dendritic Cells and B Cells. Front Immunol (2014) 0.81
Anchoring tick salivary anti-complement proteins IRAC I and IRAC II to membrane increases their immunogenicity. Vet Res (2009) 0.80
A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice. Immunology (2000) 0.79
"Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A (1978) 17.69
A severe combined immunodeficiency mutation in the mouse. Nature (1983) 13.99
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med (1991) 8.78
A theory of self-nonself discrimination. Science (1970) 7.99
Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology (1962) 6.24
INDUCTION OF IMMUNOLOGICAL PARALYSIS IN TWO ZONES OF DOSAGE. Proc R Soc Lond B Biol Sci (1964) 5.68
Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med (1982) 5.09
The regulatory role of macrophages in antigenic stimulation. Adv Immunol (1972) 4.69
Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science (1971) 4.13
Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02
THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS. J Exp Med (1965) 3.87
Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol (1990) 3.86
B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci U S A (1991) 3.84
Clonal anergy induced in mature V beta 6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells. Nature (1989) 3.44
Acquisition of immunologic self-tolerance. Cell (1989) 3.38
Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J Exp Med (1984) 3.36
Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol (1983) 3.32
The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments. J Exp Med (1967) 3.06
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med (1991) 2.60
Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc Natl Acad Sci U S A (1987) 2.57
A nondeletional mechanism of thymic self tolerance. Science (1989) 2.41
Can B cells turn on virgin T cells? Nature (1988) 2.34
Major histocompatibility complex-restricted, polyclonal B cell responses resulting from helper T cell recognition of antiimmunoglobulin presented by small B lymphocytes. J Exp Med (1985) 2.32
T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc Natl Acad Sci U S A (1988) 2.21
Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses. Cell Immunol (1989) 2.15
Distinct features of dendritic cells and anti-Ig activated B cells as stimulators of the primary mixed leukocyte reaction. J Exp Med (1989) 2.00
Mechanism of induction of immunological tolerance. IV. The effects of ultra-low doses of flagellin. Immunology (1968) 2.00
Role of membrane immunoglobulin (Ig) crosslinking in membrane Ig-mediated, major histocompatibility-restricted T cell-B cell cooperation. J Exp Med (1985) 1.98
IMMUNOLOGIC UNRESPONSIVENESS TO HETEROLOGOUS SERUM PROTEINS INDUCED IN ADULT MICE AND TRANSFER OF THE UNRESPONSIVE STATE. J Immunol (1964) 1.98
Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science (1991) 1.97
Polyclonal activation of the murine immune system by an antibody to IgD. II. Generation of polyclonal antibody production and cells with surface IgG. J Immunol (1982) 1.96
Peripheral clonal elimination of functional T cells. Science (1990) 1.69
Studies on the induction of immunologic unresponsiveness. I. Effects of endotoxin and phytochemagglutinin. J Immunol (1967) 1.47
T cells discriminate between Ia antigens expressed on allogeneic accessory cells and B cells: a potential function for carbohydrate side chains on Ia molecules. Proc Natl Acad Sci U S A (1983) 1.27
Are primary alloresponses truly primary? Int Immunol (1990) 1.21
Antigen presentation by resting B cells. Effectiveness at inducing T cell proliferation is determined by costimulatory signals, not T cell receptor occupancy. J Immunol (1990) 1.16
The B-cell clonotype repertoire. Adv Immunol (1978) 1.16
Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft. J Immunol (1989) 1.11
The induction of peripheral T cell unresponsiveness in adult mice by monomeric human gamma-globulin. J Immunol (1989) 1.09
Demonstration of mouse serum IgD. J Immunol (1979) 1.03
A peripheral mechanism preserves self-tolerance to a secreted protein in transgenic mice. J Immunol (1990) 1.02
Are B lymphocytes the principal antigen-presenting cells in vivo? J Immunol (1988) 1.02
Features of cells controlling H-2-restricted presentation of antigen to T helper cells in vivo. J Immunol (1980) 1.01
Characterization of antigen processing and presentation by resting B lymphocytes. J Immunol (1988) 1.01
Do small B cells induce tolerance? Transplant Proc (1991) 0.92
Antigen presentation in acquired immunological tolerance. FASEB J (1991) 0.87
The T cell response to allelic determinants on Igh-1-encoded IgG2a antibodies: dual recognition examined by using antigenic antibodies with binding affinity for Ia molecules. J Immunol (1983) 0.85
Isolation of a bovine serum albumin-specific T-suppressor cell clone and evaluation of its in vitro functions. Immunology (1987) 0.83
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature (2012) 7.76
Induction and suppression of polyclonal antibody responses by anti-Ig reagents and antigen-nonspecific helper factors: a comparison of the effects of anti-Fab, anti-IgM, and anti IgD on murine B cells. Immunol Rev (1980) 2.96
Major histocompatibility complex-restricted, polyclonal B cell responses resulting from helper T cell recognition of antiimmunoglobulin presented by small B lymphocytes. J Exp Med (1985) 2.32
Separable helper factors support B cell proliferation and maturation to Ig secretion. J Immunol (1982) 2.16
Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J Immunol (1984) 2.15
Human growth hormone release: relation to slow-wave sleep and sleep-walking cycles. Science (1969) 2.15
Stimulation of mouse lymphocytes by insoluble anti-mouse immunoglobulin. Nature (1975) 2.07
Effects of slow wave sleep deprivation on human growth hormone release in sleep: preliminary study. Life Sci (1969) 2.00
Role of membrane immunoglobulin (Ig) crosslinking in membrane Ig-mediated, major histocompatibility-restricted T cell-B cell cooperation. J Exp Med (1985) 1.98
Activation of murine B lymphocytes by anti-immunoglobulin is an inductive signal leading to immunoglobulin secretion. J Exp Med (1980) 1.60
B lymphocyte activation by insoluble anti-immunoglobulin: induction of immunoglobulin secretion by a T cell-dependent soluble factor. J Immunol (1979) 1.54
Fc-dependent inhibition of mouse B cell activation by whole anti-mu antibodies. J Immunol (1983) 1.50
Human growth hormone release during sleep: electroencephalographic correlation. J Clin Endocrinol Metab (1969) 1.35
Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype. J Immunol (1986) 1.29
Affinity labeling of rabbit antisaccharide antibodies. Biochemistry (1967) 1.28
Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines. J Immunol (1988) 1.27
B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc Natl Acad Sci U S A (1995) 1.27
B lymphocyte development and activation independent of MHC class II expression. J Immunol (1993) 1.25
Ameloblastic fibrosarcoma of the jaws. A clinicopathologic and DNA analysis of five cases and review of the literature with discussion of its relationship to ameloblastic fibroma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 1.24
Sleep-related, nychthermeral and briefly episodic variation in human plasma prolactin concentrations. J Clin Endocrinol Metab (1973) 1.23
Parameters of tolerance induction by antigen targeted to B lymphocytes. J Immunol (1993) 1.14
Direct triggering of B lymphocytes by insolubilized antigen. Eur J Immunol (1974) 1.13
T cell-dependent induction of NF-kappa B in B cells. J Exp Med (1993) 1.09
A mitogen for human B cells: anti-Ig coupled to polyacrylamide beads activates blood mononuclear cells independently of T cells. J Immunol (1982) 1.06
Antigen presentation by hapten-specific B lymphocytes. IV. Comparative ability of B cells to present specific antigen and anti-immunoglobulin antibody. J Immunol (1987) 1.05
Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40. J Immunol (2000) 1.04
Characterization of antigen processing and presentation by resting B lymphocytes. J Immunol (1988) 1.01
Plasma thyrotropin, thyroxine, and triiodothyronine relationships in man. J Clin Endocrinol Metab (1976) 0.95
Relation of sleep-entrained human prolactin release to REM-nonREM cycles. J Clin Endocrinol Metab (1974) 0.92
Usefulness of post-sleep human growth hormone release as a test of physiologic growth hormone secretion. J Clin Endocrinol Metab (1970) 0.92
Do small B cells induce tolerance? Transplant Proc (1991) 0.92
T cells produce TRF in response to Con A and factors in T cell hybridoma supernatants. J Immunol (1982) 0.91
Implications of growth hormone release in sleep. Metabolism (1970) 0.88
Human growth hormone release in sleep: effect of daytime exercise. J Clin Endocrinol Metab (1971) 0.88
Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig. J Immunol (1997) 0.88
Nonspecific and specific immunosuppression in tumour-bearing mice by soluble immune complexes. Nature (1975) 0.88
Intracellular localization of tyrosine kinase substrates beneath crosslinked surface immunoglobulins in B cells. J Exp Med (1991) 0.87
Human growth hormone release in sleep: nonsuppression by acute hyperglycemia. J Clin Endocrinol Metab (1971) 0.86
Antigen and helper T lymphocytes activate B lymphocytes by distinct signaling pathways. Eur J Immunol (1993) 0.86
Differences between T helper cell type I (Th1) and Th2 cell lines in signalling pathways for induction of contact-dependent T cell help. Eur J Immunol (1992) 0.86
Effect of 64-hour sleep deprivation on the circadian waveform of thyrotropin (TSH): further evidence of sleep-related inhibition of TSH release. J Clin Endocrinol Metab (1987) 0.85
CD45 alternative exon expression in murine and human CD4+ T cell subsets. J Immunol (1992) 0.85
Coexpression of B7-1 and antigen blocks tolerance induction to antigen presented by resting B cells. J Immunol (1996) 0.85
Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway. J Immunol (1998) 0.85
The nocturnal rise of plasma testosterone in pubertal boys. J Clin Endocrinol Metab (1974) 0.84
Inhibition of the sleep-related peak in physiologic human growth hormone release by somatostatin. J Clin Endocrinol Metab (1974) 0.84
Affinity labeling of anti-Group A streptococcal polysaccharide antibodies. Immunochemistry (1973) 0.84
Subclass specificity of Fc gamma receptor-mediated inhibition of mouse B cell activation. J Immunol (1985) 0.84
Analysis of low zone tolerance induction in normal and B cell-deficient mice. J Immunol (1996) 0.84
The responses of mature T cells are not necessarily antagonized by their positively selecting peptide. J Immunol (1996) 0.83
Pubertal sleep-wake patterns of episodic LH, FSH and testosterone release in twin boys. J Clin Endocrinol Metab (1975) 0.83
Induction of immunological tolerance to islet allografts. Cell Transplant (1996) 0.82
T-cell selection. A little of what you fancy ... Nature (1994) 0.81
Aggregate-free human growth hormone. II. Physicochemical and biological properties. Endocrinology (1969) 0.81
Assessment of acute and chronic changes in parathyroid hormone secretion by a radioimmunoassay with predominant specificity for the carboxy-terminal region of the molecule. J Clin Endocrinol Metab (1978) 0.81
Long term effects of nightly dexamethasone administration in patients with polycystic ovarian disease. J Clin Endocrinol Metab (1982) 0.79
Elucidation of mechanism(s) of the nocturnal rise of testosterone in men. J Clin Endocrinol Metab (1974) 0.79
Pilot study of growth hormone release in sleep of the chair-adapted baboon: potential as model of human sleep release. Endocrinology (1972) 0.79
Blunted prolactin response. A neuroendocrine abnormality manifested by depressed patients. Arch Gen Psychiatry (1982) 0.78
Effects of IL-4 and Fc gamma receptor II engagement on Egr-1 expression during stimulation of B lymphocytes by membrane immunoglobulin crosslinking. Mol Immunol (1993) 0.78
Inducible cell contact signals regulate early activation gene expression during B-T lymphocyte collaboration. J Immunol (1992) 0.78
Ethanol-related prolactin responses and risk for alcoholism. Biol Psychiatry (1983) 0.78
Nocturnal patterns of serum gonadotropins during the menstrual cycle. J Clin Endocrinol Metab (1973) 0.78
Effect of normal and reversed sleep-wake cycles upon nyctohemeral rhythmicity of plasma thyrotropin: evidence suggestive of an inhibitory influence in sleep. J Clin Endocrinol Metab (1976) 0.77
Sleep-associated gonadotrophin and oestradiol patterns in girls with precocious sexual development. Clin Endocrinol (Oxf) (1982) 0.77
Comparison between the effects of aging on antagonist and agonist interactions with beta-adrenergic receptors on human mononuclear and polymorphonuclear leukocyte membranes. J Gerontol (1988) 0.77
IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction. J Immunol (1988) 0.76
The effect of methadone on the behavioral and neuroendocrine responses of manic patients. Psychiatry Res (1982) 0.76
Induction of high affinity IL 2 receptors on B cells responding to anti-Ig and T cell-derived helper factors. J Immunol (1985) 0.75
Behavioral effects of methadone in schizophrenic patients. Am J Psychiatry (1981) 0.75
The relationship of human growth hormone and plasma tyrosine during sleep. J Clin Endocrinol Metab (1972) 0.75
Persistence of rhythmic human growth hormone release during sheep in fasted and nonisocalorically fed normal subjects. Metabolism (1972) 0.75
Arginine infusion and growth-hormone secretion. Lancet (1968) 0.75
Class II MHC molecules and antigen enter the same vesicles during internalization by resting B lymphocytes. Cell Immunol (1990) 0.75
Sleep release of human growth hormone in treated juvenile diabetics. Similarity to normal subjects and nonsuppression by hyperglycemia. Diabetes (1971) 0.75
Fc gamma receptor effects on induction of c-myc mRNA expression in mouse B lymphocytes by anti-immunoglobulin. Mol Immunol (1987) 0.75
Anti-Ig as a model for MHC-restricted help. Ann Immunol (Paris) (1984) 0.75
Fetus-in-fetu. J Indiana State Med Assoc (1974) 0.75
Sleep-wake patterns of LH and testosterone release in prepubertal boys. J Clin Endocrinol Metab (1977) 0.75